½Å°æÀçȰ ±â±â ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, ¼¼°è ¹× Áö¿ªº° Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® º¸°í¼­ : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Neurorehabilitation Devices Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User, and Geography
»óǰÄÚµå : 1591410
¸®¼­Ä¡»ç : The Insight Partners
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 169 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,450 £Ü 6,379,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.
US $ 6,450 £Ü 9,247,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,450 £Ü 12,114,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

½Å°æÀçȰ ±â±â ½ÃÀå ±Ô¸ð´Â 2023³â 27¾ï 2,000¸¸ ´Þ·¯¿¡¼­ 2031³â 70¾ï 8,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2031³â CAGRÀº 12.7%·Î ¿¹ÃøµË´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ½Å°æ ÀçȰ Àåºñ¿¡ ´ëÇÑ ÀÓ»ó ¿¬±¸ÀÇ Áõ°¡´Â ½Å°æ ÀçȰ Àåºñ ½ÃÀå ±Ô¸ð È®´ë¿¡ ±â¿©ÇÏ´Â ÁÖ¸ñÇÒ ¸¸ÇÑ ¿äÀÎÀÔ´Ï´Ù. ±×·¯³ª ½Å°æ ÀçȰ ÀåºñÀÇ ³ôÀº ºñ¿ëÀº ½Å°æ ÀçȰ Àåºñ ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

½Å°æ ÀçȰ ÀåºñÀÇ ±â¼ú ¹ßÀüÀº ȯÀÚÀÇ °á°ú, ¾ÈÀü¼º ¹× ½Å°æ Áúȯ °ü¸®ÀÇ Àü¹ÝÀûÀÎ È¿À²¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¿ö½ÌÅÏ ´ëÇÐÀÇ ½Å»ý ±â¾÷ÀÎ Neurolutions Inc.´Â IpsiHand Upper Extremity Rehabilitation SystemÀ̶ó´Â ÀåÄ¡¸¦ °³¹ßÇß½À´Ï´Ù. ³úÁ¹ÁßÀ¸·Î Àå¾Ö¸¦ ÀÔÀº »ç¶÷µéÀÌ ¸Ó¸®¸¦ »ç¿ëÇÏ¿© ÆÈ°ú ¼ÕÀÇ ±â´ÉÀ» Á¦¾îÇÒ ¼ö ÀÖµµ·Ï µ½´Â ÀÌ ÀåÄ¡´Â 2021³â 4¿ù ¹Ì±¹ ½ÄǰÀǾ౹(FDA)À¸·ÎºÎÅÍ ³ú-ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º(BCI) ±â¼úÀ» Ȱ¿ëÇÑ ÀÔ½ÃÇÚµå »óÁöÀçȰ½Ã½ºÅÛÀÇ ½ÃÆÇÇã°¡¸¦ ¹Þ¾Ò½À´Ï´Ù. 2024³â 4¿ù, Àεµ¿¡ º»»ç¸¦ µÐ K Physio and Rehab ClinicÀº ½Å°æ ÀçȰ¿¡ Çõ¸íÀ» ÀÏÀ¸Å³ Çõ½ÅÀûÀΠ÷´Ü ¿Ü°ñ°Ý ½Å°æ ÀåÄ¡(Advanced Exoskeletal Neuro Device)ÀÇ Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. 2023³â 2¿ù, ¸¶Àεå¸ÞÀÌÁî´Â ¹Ì±¹ FDA¿¡ µî·ÏµÇ°í CE ¸¶Å©¸¦ ȹµæÇÑ '¼¼°è ÃÖÃÊ' ¼Õ ¿îµ¿ ±â´É Àå¾Ö ȯÀÚ¸¦ À§ÇÑ ½º¸¶Æ® ±â±âÀÎ Izar¸¦ ¹Ì±¹°ú EU¿¡¼­ Ãâ½ÃÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ÀåÄ¡´Â ±¤¹üÀ§ÇÑ ½Å°æ Áúȯ¿¡ »ç¿ëµÇ´Â °¡Àå È¿°úÀûÀÎ ¼ÕÀÇ Á¤±³¼º ¹× ±Ù·Â Ä¡·á¹ý Áß ÇϳªÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú °³¹ßÀº ÇâÈÄ ¸î ³â µ¿¾È ½Å°æ ÀçȰ Àåºñ ½ÃÀå¿¡ »õ·Î¿î Æ®·»µå¸¦ °¡Á®¿Ã °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

¿ëµµº° ÀλçÀÌÆ®

½Å°æÀçȰ ±â±â ½ÃÀåÀº ¿ëµµº°·Î ³úÁ¹Áß, ¿Ü»ó¼º ³ú¼Õ»ó, ô¼ö¼Õ»ó, ÆÄŲ½¼º´, ³ú¼º¸¶ºñ, ±âŸ·Î ºÐ·ùµË´Ï´Ù. ³úÁ¹Áß ºÐ¾ß´Â 2023³â °¡Àå Å« ½Å°æ ÀçȰ Àåºñ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ³úÁ¹ÁßÀº ¿©ÀüÈ÷ Àü ¼¼°è Àå±â Àå¾ÖÀÇ ÁÖ¿ä ¿øÀÎ Áß ÇϳªÀ̸ç, °³Àΰú ±× °¡Á·¿¡°Ô Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿Í »ýȰ½À°üº´ÀÇ Áõ°¡·Î ÀÎÇØ ³úÁ¹Áß ¹ßº´·üÀº Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, È¿°úÀûÀÎ ÀçȰ ¼Ö·ç¼ÇÀÇ Á߿伺ÀÌ ºÎ°¢µÇ°í ÀÖ½À´Ï´Ù. °íÇ÷¾Ð, ´ç´¢º´°ú °°Àº ¸¸¼ºÁúȯÀÇ ±ÞÁõÀº ³úÁ¹Áß À¯º´·ü Áõ°¡ÀÇ ÁÖ¿ä ¿øÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¼¼°è³úÁ¹Á߱ⱸ 2024 º¸°í¼­¿¡ µû¸£¸é, Àü ¼¼°èÀûÀ¸·Î ¸Å³â 1,220¸¸ ¸íÀÌ ³úÁ¹ÁßÀ» °æÇèÇϰí 650¸¸ ¸íÀÌ »ç¸ÁÇϰí ÀÖÀ¸¸ç, 2023³â¿¡´Â ³úÁ¹ÁßÀ» °æÇèÇÑ »ç¶÷ÀÌ Àü ¼¼°èÀûÀ¸·Î 1¾ï ¸íÀ» ³Ñ¾î¼³ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. µû¶ó¼­ »ýȰ½À°üº´ÀÇ Áõ°¡·Î ÀÎÇÑ ³úÁ¹Áß À¯º´·üÀÇ Áõ°¡´Â ȸº¹À» Áö¿øÇÏ°í »îÀÇ ÁúÀ» °³¼±Çϱâ À§ÇÑ ½Å°æ ÀçȰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» º¸°í¼­´Â ¼¼°èº¸°Ç±â±¸(WHO), ¼¼°è ³úÁ¹Áß ÆÑÆ®½ÃÆ®, ÆÄŲ½¼Àç´Ü(Parkinson's Foundation) µîÀÌ ½Å°æÀçȰ ±â±â ½ÃÀå º¸°í¼­ ÀÛ¼º ½Ã Âü°íÇÑ 1Â÷ Á¤º¸ ¹× 2Â÷ Á¤º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ½Å°æÀçȰ ±â±â ½ÃÀå »óȲ

Á¦5Àå ½Å°æÀçȰ ±â±â ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

Á¦6Àå ½Å°æÀçȰ ±â±â ½ÃÀå : ¼¼°è ½ÃÀå ºÐ¼®

Á¦7Àå ½Å°æÀçȰ ±â±â ½ÃÀå ºÐ¼® - Á¦Ç° À¯Çüº°

Á¦8Àå ½Å°æÀçȰ ±â±â ½ÃÀå ºÐ¼® - ¿ëµµº°

Á¦9Àå ½Å°æÀçȰ ±â±â ½ÃÀå ºÐ¼® - ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ½Å°æÀçȰ ±â±â ½ÃÀå - Áö¿ªº° ºÐ¼®

Á¦11Àå ½Å°æÀçȰ ±â±â ½ÃÀå : ¾÷°è »óȲ

Á¦12Àå ±â¾÷ °³¿ä

Á¦13Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The neurorehabilitation devices market size is expected to grow from US$ 2.72 billion in 2023 to US$ 7.08 billion by 2031; it is projected to register a CAGR of 12.7% during 2023-2031. The increasing prevalence of neurological diseases worldwide and the growing number of clinical studies on neurorehabilitation devices are noteworthy factors contributing to the expansion of the neurorehabilitation devices market size. However, the high cost of neurorehabilitation devices hinders the neurorehabilitation devices market growth.

Technological advancements in neurorehabilitation devices are improving patient outcomes, safety, and the overall efficiency of neurological disease management. Neurolutions Inc., a Washington University startup company, developed a device called the IpsiHand Upper Extremity Rehabilitation System, which helps people disabled by stroke regain control over their arm and hand function by using their minds. In April 2021, the company received market authorization from the Food and Drug Administration (FDA) for its IpsiHand Upper Extremity Rehabilitation System, which leverages brain-computer interface (BCI) technology licensed by the university. In April 2024, India-based K Physio and Rehab Clinic announced the launch of the ground-breaking Advanced Exoskeletal Neuro Device, revolutionizing neurorehabilitation. The device provides faster recovery to fully and partially paralyzed patients. In February 2023, MindMaze announced the US and EU launch of Izar, a "first-of-its-kind" US FDA-listed and CE-marked smart device for patients with impairment in hand motor function. The device is one of the most effective hand dexterity and strength treatments used in a wide range of neurological conditions. Such technological developments are likely to bring new trends in the neurorehabilitation devices market in the coming years.

Application -Based Insights

Based on application, the neurorehabilitation devices market is segmented into stroke, traumatic brain injury, spinal cord injury, Parkinson's disease, cerebral palsy, and others. The stroke segment held the largest neurorehabilitation devices market share in 2023. Stroke remains one of the leading causes of long-term disability worldwide, significantly impacting individuals and their families. As the global population ages and lifestyle diseases increase, the incidence of stroke is projected to rise, highlighting the critical need for effective rehabilitation solutions. The surge in cases of chronic disorders such as hypertension and diabetes are a major contributing factor to the increasing prevalence of stroke. According to the World Stroke Organization 2024 report, globally, 12.2 million people experience stroke every year, leading to 6.5 million deaths, and there were more than 100 million people in the world who experienced stroke in 2023. Therefore, the growing prevalence of stroke, owing to increasing lifestyle diseases, is expected to create a demand for neurorehabilitation to support recovery and improve the quality of life.

The World Health Organization, Global Stroke Fact Sheet, and Parkinson's Foundation are among the primary and secondary sources referred to while preparing the neurorehabilitation devices market report.

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Neurorehabilitation Devices Market Landscape

5. Neurorehabilitation Devices Market - Key Market Dynamics

6. Neurorehabilitation Devices Market - Global Market Analysis

7. Neurorehabilitation Devices Market Analysis - by Product Type

8. Neurorehabilitation Devices Market Analysis - by Application

9. Neurorehabilitation Devices Market Analysis - by End User

10. Neurorehabilitation Devices Market - Geographical Analysis

11. Neurorehabilitation Devices Market - Industry Landscape

12. Company Profiles

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â